StonvexLoading…
StonvexCore line items from GH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $982.02M | $739.02M | $563.95M |
Operating Income | $-437.25M | $-443.59M | $-564.73M |
Net Income | $-416.28M | $-436.37M | $-479.45M |
EPS (Diluted) | $-3.32 | $-3.56 | $-4.28 |
Total Assets | $2.01B | $1.49B | $1.79B |
Total Liabilities | $2.11B | $1.63B | $1.63B |
Cash & Equivalents | $378.20M | $525.54M | $1.13B |
Free Cash Flow OCF − CapEx | $-233.07M | $-274.94M | $-345.46M |
Shares Outstanding | 130.64M | 123.99M | 121.63M |